Tagged with MSD

Cyprus   Jacqueline Anastassiades has been involved in the development of the Cypriot healthcare sector for more than 10 years as the Managing Director of MSD. With the upcoming healthcare reforms, she brings her expert insights into the key requirements the Cyprus national health system should validate as well as the…

UK Having just announced a major investment into a new UK Discovery Centre in London that is set to open in 2020, MSD is committed to leverage on the UK’s potential in driving forward early stage discovery. Louise Houson, Managing Director for the UK and Ireland explains the reasons for that…

Portugal The top 20 pharma companies in Portugal ranked by sales and market share for the year leading up to March 2018. MSD leads the way with EUR 148 million in sales and a 5.4 percent market share, followed by Mylan and Bayer.

India A strong supporter of public-private partnerships, MSD’s managing director in India, Vivek Kamath, explains how the company’s collaborative approach is the key to enhancing their reputation, improving patient outcomes and tackling unmet medical needs in India.   Mr. Kamath, you have worked for MSD for over four years and you…

Serbia Nebojsa Skuljec has held various positions in MSD Healthcare across the Balkans before his promotion to country lead for Serbia and Balkans emerging markets 14 months ago. In this interview Skuljec tells the story of MSD’s journey from humble origins to one of the big pharma players in Serbia, growth…

Poland Denis Vujičić, managing director of MSD Poland, discusses his overriding mission to give Polish patients greater access to breakthrough therapies and highlights the affiliate’s extensive R&D capabilities that entail both domestic and global operations. Furthermore, he highlights the important steps that MSD is undertaking to strengthen its position as the…

Bulgaria Urszula Orzel, general manager at MSD Bulgaria, explains how the affiliate has become one of the fastest growing players in the country and emphasizes that pharmaceutical companies are not merely manufacturers of drugs, but should also be socially committed. This is your first time as a country manager. How did…

Colombia With Latin America’s best healthcare system in terms of both coverage and quality, Colombia is fast becoming a destination of choice for multinationals, not only to set up shop in the sense of establishing a direct local affiliate, but also for opening regional headquarters and implanting managerial functions. “We are…

Colombia Guillermo Browne, General Manager at MSD Colombia, reveals the strategic importance of the Colombian affiliate, hosting a global data management centre and regional pharmacovigilance operations, while highlighting the company’s commitment to continue advancing the therapeutic value of care and the clinical research landscape in Colombia. With 70 years of presence…

Indonesia Ashish D. Pal, President Director at MSD Indonesia, discusses the importance of introducing innovative pharmaceuticals, vaccines and biologics to address significant unmet needs and the strategic importance of the universal healthcare coverage program (JKN) towards meeting the national healthcare goals. Mr. Pal, you have been leading the Indonesian affiliate of…

Ireland Much like the Irish sport of hurling, conducting R&D in Ireland is something often overlooked – unfairly, as proponents would say. Ireland has always faced a number of intrinsic hurdles in this space, not least the small patient population and more recently, the economic crisis, which forced the Irish healthcare…

Asia Despite underdevelopment in many facets; Southeast Asia is actually at the forefront of a digital revolution in healthcare; with digital solutions helping bring about more efficient, cost-effective, and tailored patient care. “Cloud-based technology, mobile enablement and fees for service models will lead to faster deployment and increased benefits for patients.…